What is it about?
Mesenchymal stem cell (MSC)-based therapy has been applicated in clinical settings for decades. Our review summarized the use of MSCs for ARDS patients in preclinical and clinical studies and discussed the application of MSCs for patients with COVID-19 and the related important issues.
Photo by CDC on Unsplash
Why is it important?
Our review showed that mesenchymal stem cell (MSC)-based therapy has been widely used for treatment of ARDS patients. Thus, according to the similar mechanism, MSC-based therapy should be a promising approach for COVID-19 patients.
Read the Original
This page is a summary of: Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential, Current Stem Cell Research & Therapy, February 2021, Bentham Science Publishers,
You can read the full text:
The following have contributed to this page